Product Information

BRINZOLAMIDE 1% EYE DROPS is a generic product labeled by Bausch & Lomb Incorporated, priced at $7.9504 per ML under NDC 24208046410. Its NADAC has been published 54 times since Nov 5, 2025.

FDA first approved this application on Aug 18, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRINZOLAMIDE 1% EYE DROPS

brinzolamide
$7.9504per ML

Strength

10 mg/mL

NDC

24208046410

Classification

Generic

Dosage Form

SUSPENSION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

BRINZOLAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204884

FDA Approved

8/18/2021

TE Code

AB

On Market Since

3/31/2022

Pharmacological Classes

Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors

Price Statistics

The NADAC for BRINZOLAMIDE 1% EYE DROPS has been published 54 times since Nov 5, 2025, and over the history we have for it it has declined 21.0%. The table below summarizes its recorded NADAC range and movement.

Current price$7.9504 per ML
All-time high$12.9336 (Feb 11, 2026)
All-time low$7.9504 (Oct 21, 2026)
52-week high$12.9336
52-week low$7.9504
Median price$10.1057
Average price$10.3886
Largest weekly change+21.7% (Nov 19, 2025)
Weeks tracked54
Tracking sinceNov 5, 2025

Price History

1W

0.0%

1M

-6.8%

3M

-18.7%

6M

-21.3%

1Y

-21.0%

3Y

N/A

5Y

N/A

All

-21.0%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRINZOLAMIDE 1% EYE DROPS?

The current National Average Drug Acquisition Cost (NADAC) for BRINZOLAMIDE 1% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $7.9504 per ML (NDC 24208046410), effective Nov 11, 2026.

How has the price of BRINZOLAMIDE 1% EYE DROPS changed over time?

Over the history we have for it, the NADAC for BRINZOLAMIDE 1% EYE DROPS has declined 21.0%. It has been tracked across 54 weekly CMS publications since Nov 5, 2025.

What are the highest and lowest recorded NADAC prices for BRINZOLAMIDE 1% EYE DROPS?

Since Nov 5, 2025, the NADAC for BRINZOLAMIDE 1% EYE DROPS has ranged from a low of $7.9504 (Oct 21, 2026) to a high of $12.9336 (Feb 11, 2026), with a median of $10.1057 per ML.

Are there cheaper alternatives to BRINZOLAMIDE 1% EYE DROPS?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BRINZOLAMIDE 1% EYE DROPS in a comparable dosage form, but none are currently priced below it.

Who manufactures BRINZOLAMIDE 1% EYE DROPS?

BRINZOLAMIDE 1% EYE DROPS (NDC 24208046410) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.